Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Curr Med Res Opin. 2016 Mar 2;32(6):991–996. doi: 10.1185/03007995.2016.1149056

Table 1.

Treatment sequences for HER2-positive metastatic breast cancer.

Sequences First line Second line Third line
1 Pertuzumab + trastuzumab + docetaxel T-DM1 Capecitabine + lapatinib
2 Pertuzumab + trastuzumab + docetaxel Trastuzumab + lapatinib Trastuzumab + capecitabine
3 Trastuzumab + docetaxel T-DM1 Trastuzumab + lapatinib
4 Trastuzumab + docetaxel Trastuzumab + lapatinib Trastuzumab + capecitabine

T-DM1: trastuzumab emtansine.